27 Mar 2014

Participants sought: An adjunctive pro-cognitive treatment in schizophrenia

This study by Monash Alfred Psychiatry Research Centre (MAPrc) is being conducted in order to determine if two different doses of EVP-6124 improve mental function and are safe in people who have schizophrenia and are taking another medication for their illness.
Contact: Mr Daniel Grice ph (03) 9076 6581 Email participate.maprc@monash.edu

No comments:

Post a Comment

Thankyou for your comment. We moderate all messages and may take a little time to review your comment. Please email inquiries to ccs.comms@monash.edu.

Related Posts Plugin for WordPress, Blogger...